Altimmune, Inc. (NYSEARCA:ALT) Director Derace L. Schaffer purchased 33,315 shares of the business’s stock in a transaction on Thursday, November 30th. The shares were acquired at an average price of $1.91 per share, for a total transaction of $63,631.65. Following the completion of the acquisition, the director now directly owns 274,238 shares in the company, valued at approximately $523,794.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Altimmune, Inc. has a 12 month low of $49.37 and a 12 month high of $54.24.
Separately, Piper Jaffray Companies initiated coverage on Altimmune in a report on Monday, October 9th. They set an “overweight” rating and a $6.00 price target on the stock.
iShares Diversified Alternatives Trust (the Trust) is a commodity pool. The investment objective of the Trust is to maximize absolute returns from its investments in certain futures and/or forward contracts. The Trust holds long and/or short positions in foreign currency forward contracts and exchange-traded futures contracts involving assets, such as commodities, currencies, interest rates or certain eligible stock and/or bond indices.
Receive News & Ratings for Altimmune Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altimmune Inc. and related companies with MarketBeat.com's FREE daily email newsletter.